ENTITY

Verseon Corporation (VSN LN)

Health CareUnited States
Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. It conducts drug discovery programs in the areas of anticoagulation, diabetic macular edema, and oncology. The company is involved in developing oral antico-agulants for various cardiovascular indications with novel pharmacology; potent kallikrein inhibitors for the treatment of diabetic macular edema delivered through topical eye drops; and novel angiogenesis inhibitors for the treatment of solid organ tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x